Interim Dividend of Rs 2 per share declared; Q3 revenue up 42% YoY

Corporate Actions View source PDF Explain this filing

INNOVACAP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹651.30

prior close

₹740.25

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.1%+5.0% vs market

Pharmaceuticals peers, median of 155sector-1.5%+4.4% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 4.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

+1.8

15m

+0.9

30m

-2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9-2.1+5.0-1.5+4.4

Next day

+6.3-2.0+8.3-2.1+8.4

+6.9-0.0+7.0-1.0+7.9

+3.2-0.4+3.6-1.4+4.6

+5.3+1.4+3.9-1.1+6.4

+5.8+0.1+5.7-1.4+7.1

+9.8+5.2+4.6+1.4+8.4

15d

+3.3+3.7-0.3+0.0+3.3

+5.9+3.5+2.4+0.3+5.7

+3.3-9.4+12.7-9.9+13.3

+11.3+9.0+2.3+2.5+8.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board declared an interim dividend of Rs 2 per share (20% of face value Rs 10), with record date fixed as 30 Jan 2026. Q3 FY26 consolidated revenue grew 42% YoY to Rs 4,503 million; net profit rose 23% YoY to Rs 421 million. 9M FY26 revenue stood at Rs 11,822 million (up 27% YoY) with profit of Rs 1,028 million. Q3 EPS was Rs 7.37. Auditors issued an unmodified review report.

Likely market impact

Shareholders on records as of 30 Jan 2026 will receive Rs 2 per share. Strong revenue growth signals positive momentum for the stock.